Zhiyong Xu

Dr. Zhiyong Xu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
YHYing Huang
Ying Huang
AFAihui Feng
Aihui Feng
YLYang Lin
Yang Lin
HGHengle Gu
Hengle Gu
HCHua Chen
Hua Chen
ZXZhiyong Xu
Zhiyong Xu
Background: This study was designed to establish radiation pneumonitis (RP) prediction models using dosiomics and/or deep learning-based radiomics (DLR) features based on 3D dose distribution. Methods: A total of 140 patients with non-small cell lung cancer who received stereotactic body radiation therapy (SBRT) were retrospectively included in this study. These patients were randomly divided into the training (n = 112) and test (n = 28) sets. Besides, 107 dosiomics features were extracted by Pyradiomics, and 1316 DLR features were extracted by ResNet50. Feature visualization was performed based on Spearman’s correlation coefficients, and feature selection was performed based on the least absolute shrinkage and selection operator. Three different models were constructed based on random forest, including (1) a dosiomics model (a model constructed based on dosiomics features), (2) a DLR model (a model constructed based on DLR features), and (3) a hybrid model (a model constructed based on dosiomics and DLR features). Subsequently, the performance of these three models was compared with receiver operating characteristic curves. Finally, these dosiomics and DLR features were analyzed with Spearman’s correlation coefficients. Results: In the training set, the area under the curve (AUC) of the dosiomics, DLR, and hybrid models was 0.9986, 0.9992, and 0.9993, respectively; the accuracy of these three models was 0.9643, 0.9464, and 0.9642, respectively. In the test set, the AUC of these three models was 0.8462, 0.8750, and 0.9000, respectively; the accuracy of these three models was 0.8214, 0.7857, and 0.8571, respectively. The hybrid model based on dosiomics and DLR features outperformed other two models. Correlation analysis between dosiomics features and DLR features showed weak correlations. The dosiomics features that correlated DLR features with the Spearman’s rho |ρ| ≥ 0.8 were all first-order features. Conclusion: The hybrid features based on dosiomics and DLR features from 3D dose distribution could improve the performance of RP prediction after SBRT.

23 September 2020 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
YSYan Shao
Yan Shao
XZXiaoying Zhang
Xiaoying Zhang
GWGe Wu
Ge Wu
QGQingtao Gu
Qingtao Gu
JWJiyong Wang
Jiyong Wang
ZXZhiyong Xu
Zhiyong Xu
The iterative design of radiotherapy treatment plans is time-consuming and labor-intensive. In order to provide a guidance to treatment planning, Asymmetric network (A-Net) is proposed to predict the optimal 3D dose distribution for lung cancer patients. A-Net was trained and tested in 392 lung cancer cases with the prescription doses of 50Gy and 60Gy. In A-Net, the encoder and decoder are asymmetric, able to preserve input in-formation and to adapt the limitation of GPU memory. Squeeze and excitation (SE) units are used to improve the data-fitting ability. A loss function involving both the dose distribution and prescription dose as ground truth are designed. In the experiment, A-Net is separately trained and tested in the 50Gy and 60Gy da-taset and most of the metrics A-Net achieve similar performance as HD-Unet and 3D-Unet, and some metrics slightly better. In the 50Gy-and-60Gy-combined dataset, most of the A-Net's metrics perform better than the other two. In conclusion, A-Net can ac-curately predict the IMRT dose distribution in the three datasets of 50Gy and 50Gy-and-60Gy-combined dataset.

20 July 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
YHYing Huang
Ying Huang
YPYifei Pi
Yifei Pi
KMKui Ma
Kui Ma
XMXiaojuan Miao
Xiaojuan Miao
SFSichao Fu
Sichao Fu
ZXZhiyong Xu
Zhiyong Xu
The dose verification in radiotherapy quality assurance (QA) is time-consuming and places a heavy workload on medical physicists. To provide a clinical tool to perform patient specific QA accurately, the UNet++ is investigated to classify failed or pass fields (the GPR lower than 85% is considered “failed” while the GPR higher than 85% is considered “pass”), predict gamma passing rates (GPR) for different gamma criteria, and predict dose difference from virtual patient-specific quality assurance in radiotherapy. UNet++ was trained and validated with 473 fields and tested with 95 fields. All plans used Portal Dosimetry for dose verification pre-treatment. Planar dose distribution of each field was used as the input for UNet++, with QA classification results, gamma passing rates of different gamma criteria, and dose difference were used as the output. In the test set, the accuracy of the classification model was 95.79%. The mean absolute error (MAE) were 0.82, 0.88, 2.11, 2.52, and the root mean squared error (RMSE) were 1.38, 1.57, 3.33, 3.72 for 3%/3mm, 3%/2 mm, 2%/3 mm, 2%/2 mm, respectively. The trend and position of the predicted dose difference were consistent with the measured dose difference. In conclusion, the Virtual QA based on UNet++ can be used to classify the field passed or not, predict gamma pass rate for different gamma criteria, and predict dose difference. The results show that UNet++ based Virtual QA is promising in quality assurance for radiotherapy.

17 November 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
HWHao Wang
Hao Wang
YZYongkang Zhou
Yongkang Zhou
Xiao WangXiao Wang
Xiao Wang
YZYin Zhang
Yin Zhang
CMChi Ma
Chi Ma
KNKe Nie
Ke Nie
Purpose: This study was conducted in order to determine the reproducibility and repeatability of cone-beam computed tomography (CBCT) radiomics features.Methods: The first-, second-, and fifth-day CBCT images from 10 head and neck (H&N) cancer patients and 10 pelvic cancer patients were retrospectively collected for this study. Eighteen common radiomics features were extracted from the longitudinal CBCT images using two radiomics packages. The reproducibility of CBCT-derived radiomics features was assessed using the first-day image as input and compared across the two software packages. The site-specific intraclass correlation coefficient (ICC) was used to quantitatively assess the agreement between packages. The repeatability of CBCT-based radiomics features was evaluated by comparing the following days of CBCT to the first-day image and quantified using site-specific concordance correlation coefficient (CCC). Furthermore, the correlation with volume for all the features was assessed with linear regression and R2 as correlation parameters.Results: The first-order histogram-based features such as skewness and entropy showed good agreement computed in either software package (ICCs ≥ 0.80), while the kurtosis measurements were consistent in H&N patients between the two software tools but not in pelvic cases. The ICCs for GLCM-based features showed good agreement (ICCs ≥ 0.80) between packages in both H&N and pelvic groups except for the GLCM-correction. The GLRLM-based texture features were overall less consistent as calculated by the two different software packages compared with the GLCM-based features. The CCC values of all first-order and second-order GLCM features (except GLCM-energy) were all above 0.80 from the 2-day part test–retest set, while the CCC values all dropped below the cutoff after 5-day treatment scans. All first-order histogram-based and GLCM-texture-based features were not highly correlated with volume, while two GLRLM features, in both H&N and pelvic cohorts, showed R2 ≥0.8, meaning a high correlation with volume.Conclusion: The reproducibility and repeatability of CBCT-based radiomics features were assessed and compared for the first time on both H&N and pelvic sites. There were overlaps of stable features in both disease sites, yet the overall stability of radiomics features may be disease-/protocol-specific and a function of time between scans.

29 December 2023 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
YDYanhua Duan
Yanhua Duan
JWJiyong Wang
Jiyong Wang
PWPuyu Wu
Puyu Wu
YSYan Shao
Yan Shao
HCHua Chen
Hua Chen
ZXZhiyong Xu
Zhiyong Xu

2 September 2021 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
JCJindong Chen
Jindong Chen
MZMengmeng Zhou
Mengmeng Zhou
HWHao Wang
Hao Wang
ZZZhihuang Zheng
Zhihuang Zheng
WRWenwen Rong
Wenwen Rong
LZLiang Zhao
Liang Zhao